期刊
PSYCHOPHARMACOLOGY
卷 201, 期 1, 页码 115-123出版社
SPRINGER
DOI: 10.1007/s00213-008-1252-2
关键词
Nesfatin-1; Anxiety; Fear; Elevated plus maze; Novelty; Fear-potentiated startle; Conditioned emotional response
资金
- Canadian Institutes of Health Research (CIHR)
- Natural Science and Engineering Research Council of Canada (NSERC)
Rationale Nesfatin-1, derived from the protein NEFA/nucleobindin2 (NUCB2), is a newly identified peptide that acts as a potent satiety agent. It has been reported that peptides involved in the regulation of ingestive behavior are also involved in the regulation of the stress response. However, the relation between nesfatin-1 and stressor-related behaviors like anxiety and/or fear has not yet been investigated. Objective The effects of intracerebroventricular (ICV) injection of nesfatin-1 (0, 5, and 25 pmol/3 mu l) were assessed in several paradigms that are thought to reflect anxiety and/or fear in rats. Results Consistent with an anxiogenic effect, nesfatin-1 dose-dependently decreased the percentage of time spent on the open arms of the elevated plus maze, increased latency to approach, and decreased consumption of a palatable snack in an anxiogenic (unfamiliar) environment. Moreover, ICV nesfatin-1 increased the fear-potentiated startle response and the time spent freezing to both context and conditioned cues in a conditioned emotional response test. Conclusions These findings suggest that in addition to its role as a satiety peptide, nesfatin-1 may also be involved in the mediation of anxiety- and/or fear-related responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据